[Translation] A randomized, double-blind, placebo-controlled, parallel-center phase III clinical trial to investigate the efficacy and safety of Bufei Huoxue Capsules in treating chronic obstructive pulmonary disease (Qi deficiency and blood stasis syndrome).
确证性评价补肺活血胶囊治疗慢性阻塞性肺疾病(COPD)稳定期(气虚血瘀证)的有效性和安全性,为本品注册申报提供依据。
[Translation] To confirm the efficacy and safety of Bufei Huoxue Capsules in treating stable chronic obstructive pulmonary disease (COPD) (Qi deficiency and blood stasis syndrome), and to provide a basis for the registration application of this product.